These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis. Kalinowski L; Dobrucki IT; Malinski T J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):585-95. PubMed ID: 12512694 [TBL] [Abstract][Full Text] [Related]
43. Simvastatin increases the activity of endothelial nitric oxide synthase via enhancing phosphorylation. Li X; Wang P; Xu X; Wang Y; Xia Y; Wang D J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):286-90. PubMed ID: 19513607 [TBL] [Abstract][Full Text] [Related]
44. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice. Cho DH; Park JH; Joo Lee E; Jong Won K; Lee SH; Kim YH; Hwang S; Ja Kwon K; Young Shin C; Song KH; Jo I; Han SH Free Radic Biol Med; 2014 Nov; 76():96-106. PubMed ID: 25150199 [TBL] [Abstract][Full Text] [Related]
51. [Bezafibrate up-regulate endothelial nitric oxide gene expressions via peroxisome proliferator-activated receptors alpha-dependent and independent pathways in cultured Bovine endothelial cells]. Wang Y; Wang Y; Wang DW Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):530-6. PubMed ID: 16842672 [TBL] [Abstract][Full Text] [Related]
52. Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries. Rossoni LV; Wareing M; Wenceslau CF; Al-Abri M; Cobb C; Austin C Clin Sci (Lond); 2011 Nov; 121(10):449-58. PubMed ID: 21671887 [TBL] [Abstract][Full Text] [Related]
53. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Amin-Hanjani S; Stagliano NE; Yamada M; Huang PL; Liao JK; Moskowitz MA Stroke; 2001 Apr; 32(4):980-6. PubMed ID: 11283400 [TBL] [Abstract][Full Text] [Related]
54. Identification of protein phosphatase involvement in the AT Peluso AA; Bertelsen JB; Andersen K; Mortsensen TP; Hansen PB; Sumners C; Bader M; Santos RA; Steckelings UM Clin Sci (Lond); 2018 Apr; 132(7):777-790. PubMed ID: 29540539 [TBL] [Abstract][Full Text] [Related]
55. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Skaletz-Rorowski A; Lutchman M; Kureishi Y; Lefer DJ; Faust JR; Walsh K Cardiovasc Res; 2003 Jan; 57(1):253-64. PubMed ID: 12504836 [TBL] [Abstract][Full Text] [Related]
56. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. Michell BJ; Harris MB; Chen ZP; Ju H; Venema VJ; Blackstone MA; Huang W; Venema RC; Kemp BE J Biol Chem; 2002 Nov; 277(44):42344-51. PubMed ID: 12171920 [TBL] [Abstract][Full Text] [Related]
57. TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Kim F; Gallis B; Corson MA Am J Physiol Cell Physiol; 2001 May; 280(5):C1057-65. PubMed ID: 11287317 [TBL] [Abstract][Full Text] [Related]
58. Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells. Meda C; Plank C; Mykhaylyk O; Schmidt K; Mayer B Pharmacol Rep; 2010; 62(1):100-12. PubMed ID: 20360620 [TBL] [Abstract][Full Text] [Related]
59. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Haynes MP; Sinha D; Russell KS; Collinge M; Fulton D; Morales-Ruiz M; Sessa WC; Bender JR Circ Res; 2000 Oct; 87(8):677-82. PubMed ID: 11029403 [TBL] [Abstract][Full Text] [Related]
60. Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation. Wang L; Wu B; Sun Y; Xu T; Zhang X; Zhou M; Jiang W Br J Anaesth; 2010 May; 104(5):606-12. PubMed ID: 20348139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]